Glenn David is Executive Vice President and Group President for U.S. Operations, Global Diagnostics and BioDevices of Zoetis, the world's leading animal health company and a member of the Fortune 500. In this role, he is responsible for commercial operations supporting the companion animal and livestock portfolios across the U.S. In addition, he oversees the company’s Global Diagnostics, Global BioDevices, Pumpkin Pet Insurance and Platinum Performance organizations.
As a business leader in animal health for more than a decade, Mr. David brings broad industry experience to running businesses and making investments that have driven Zoetis’ growth. As a member of the Zoetis Executive team since 2016, he has played a pivotal role in supporting the company’s product launches, scrutinizing new business opportunities, and investing in global expansion initiatives.
Most recently, Mr. David was Group President of International Operations, Aquaculture, BioDevices and Pet Insurance. He previously served as Chief Financial Officer from 2016-2021 and maintained a well-capitalized and financially disciplined business, creating significant value for shareholders. As Senior Vice President of Finance Operations, he helped lead Zoetis through its Initial Public Offering (IPO) in 2013 and established the company’s financial structure and foundation.
Prior to the Zoetis IPO, Mr. David served in various financial roles at Pfizer, including Vice President of Global Finance for Pfizer Animal Health and Vice President of Finance for the U.S. Primary Care franchise. Mr. David also played important financial roles in Pfizer’s integration of the Pharmacia, Wyeth and King Pharmaceuticals’ acquisitions. Prior to joining Pfizer in 1999, Mr. David gained valuable financial experience at Bankers Trust, Paine Webber and Credit Suisse.
Mr. David graduated magna cum laude with a bachelor’s degree in Finance from Binghamton University, and he earned his MBA in Finance/Information Technology from New York University.